
Yabro 0.18% is a sodium hyaluronate-based aerosol solution, indicated as a symptomatic supportive treatment for patients with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) or idiopathic pulmonary fibrosis . Thanks to its viscoelastic, hydrating, and mucoadhesive properties, sodium hyaluronate helps improve respiratory function by keeping bronchial mucosa hydrated and promoting airflow.
Each pack contains 10 single-dose 5 ml vials , easily administered via aerosol therapy devices (pneumatic or ultrasonic nebulizers). Yabro is free of preservatives and propellant gases and is well tolerated even by patients with highly sensitive bronchi.
Directions
When is Yabro 0.18% indicated?
Yabro 0.18% is indicated for inhalation use in the following cases:
- Symptomatic treatment in patients with COPD , to reduce bronchial irritation and promote mucus thinning.
- Relief of symptoms in patients with idiopathic pulmonary fibrosis , contributing to the improvement of respiratory comfort.
- Supports airway hydration in the presence of persistent dry cough, chronic bronchitis, emphysema or other obstructive diseases.
Thanks to its composition based on 0.18% sodium hyaluronate, Yabro has an emollient and protective action on the bronchial mucosa, reducing the frequency and intensity of coughs and promoting a natural mucolytic action.
Dosage and method of use
How do I take Yabro 0.18%?
The product is intended for inhalation only using aerosol devices. It is recommended:
- One 5 ml vial once or twice a day, as directed by your doctor.
- Do not dilute or mix with other medications in the same nebulizer chamber unless otherwise prescribed by your doctor.
- Use a compressor or ultrasonic nebulizer.
- Inhale the entire contents of the vial in a single session, lasting an average of 10-15 minutes.
IMPORTANT: The vial is a single-dose vial and should be opened only immediately before use. Any unused portion should be discarded.
Contraindications
What are the main contraindications of Yabro 0.18%?
Do not use Yabro if you have:
- Known hypersensitivity to sodium hyaluronate or to any of the excipients.
- Infants and children under 2 years of age, unless specifically prescribed by a doctor.
- Concomitant use with drugs not compatible for nebulization, unless otherwise indicated by the doctor.
Side effects
What are the side effects of Yabro 0.18%?
Yabro is generally well tolerated. In rare cases, the following may occur:
- Mild irritation of the upper respiratory tract after administration.
- Rarely, feeling of chest tightness or reflex cough during inhalation.
- Local allergic reactions in sensitive subjects.
In case of severe or persistent adverse reactions, discontinue treatment and consult your doctor.
Warnings
What are the warnings of Yabro 0.18%?
- Inhalation use. Do not swallow or inject.
- Do not use damaged vials or vials with altered contents.
- Keep out of reach of children.
- Use the product immediately after opening the bottle.
- Store away from heat or humidity and do not freeze.
Expiration and storage
What are the expiration dates and storage times of Yabro 0.18%?
Yabro has a shelf life of 36 months from the date of manufacture. Store in a cool, dry place, below 25°C.
Do not use after the expiration date printed on the package. Once opened, the contents should be used immediately and not stored for later use.
Format
Pack of 10 single-dose 5 ml vials of aerosol solution.








